Drug Discovery World

MAY 6, 2024

In an example of venture capital in the city, another AI-driven biotech Aqemia raised €30 million in January 2024 in an extension to its Series A financing, bringing total funding for the round to an impressive €60 million. This knowledge base will accelerate the sector and encourage new companies.

Drugs 147

Drugs Molecular Biology Science Clinical Trials 147

Drug Discovery World

JANUARY 9, 2024

In a first for 2024, DDW will be hosting the SLAS Ignite Theater track on the theme of ‘Innovation & technology: from lab to patient’. It will take place at SLAS2024 in Boston on 5 and 6 February 2024 and is co-sponsored by Integra Biosciences and Hamamatsu Corporation.

Clinical Trials 162

Clinical Trials Drugs Science Trials 162

Drug Discovery World

DECEMBER 26, 2023

We are excited to enter into this partnership with Shionogi, a company sharing the same patient centric values as Sobi and look forward to launching cefiderocol from 2024.” Dr Isaac Chan, an Assistant Professor in UT Southwestern’s Departments of Internal Medicine and Molecular Biology, will be the primary advisor for the collaboration.

Small Molecule 130

Small Molecule Drugs Molecular Biology Bioinformatics 130

Drug Discovery World

MARCH 12, 2024

DDW Volume 25 – Issue 1, Winter 2023/2024 Biography: Michael Krogh Jensen is a Co-founder and CEO of Biomia, founded in 2022. With the acknowledged and clinically proven link between MIA chemistry and target diseases discovery programmes derived from MIAs are considered an excellent departure point for Biomia to build our pipelines.

Small Molecule 147

Small Molecule Synthetic Chemistry Production Molecular Biology 147

Alta Sciences

MARCH 1, 2024

Q&A With Dr. Norbert Makori and Pierre Jolicoeur: The Benefits of Combining Preclinical and Bioanalytical for Your Gene Therapy Studies pmjackson Fri, 03/01/2024 - 22:20 Recent advances in gene therapy have allowed for diseases to be approached differently. Q: What Platforms and Capabilities Does Altasciences Utilize for Gene Therapy Studies?

Therapies 52

Therapies Laboratories Molecular Biology RNA 52

Vial

MARCH 1, 2024

from 2024 to reach US$129.8 Recent advancements In February 2024, PPD announced the addition of mycoplasma and biosafety testing capabilities to its good manufacturing practices (GMP) lab in Wisconsin, US. As a result, the global CRO market is estimated to grow at a compound annual growth rate (CAGR) of 9.6% billion by 2029.

Clinical Trials 52

Clinical Trials Clinical Research Laboratories Trials 52

Drug Target Review

FEBRUARY 26, 2024

Her research focus is on epigenetic regulation of melanoma and other cancers as well as wound healing, ageing biology and the development of novel epigenetic therapies targeting cancers and skin diseases and she is the owner of 15 issued and pending patents relevant to her research.

Therapies 58

Therapies Molecular Biology Regulations Medical Schools 58

Broad Institute

MAY 14, 2024

William Studier for development of widely used protein- and RNA-production platform By Corie Lok May 14, 2024 Breadcrumb Home Merkin Prize in Biomedical Technology awarded to F. By Broad Communications May 14, 2024 F. Studier will be honored in a prize ceremony held on September 17, 2024. Photo courtesy of BNL.

RNA 84

RNA Production Molecular Biology Laboratories 84

Broad Institute

APRIL 25, 2024

By Allessandra DiCorato April 25, 2024 As night fell on July 20th, 2014, genomicist Christian Happi was at home with his family in Lagos, Nigeria when he received a phone call he would never forget.

Virus 132

Virus Hospitals Disease Government 132

Drug Discovery World

APRIL 30, 2024

This novel approach allows for the modulation of mRNA biology to either increase or decrease protein production, offering the versatility to target a wide range of mechanisms of action (MOA),” Slonim states. At the start of 2024, the first patients in a clinical trial investigating an mRNA cancer therapy were dosed.

Therapies 130

Therapies RNA Vaccine Small Molecule 130

Drug Target Review

JULY 1, 2024

Scientific Reports 14, 11103 (2024). He was bestowed the 2024 NIH HEAL Director’s Trailblazer Award for this work. Dr Hernan Bazan received a BS in molecular biology from Vanderbilt University and has spent two years in medical school as a Howard Hughes Medical Institute (HHMI) Research Scholar at the NIH.

Treatment 52

Treatment Clinical Trials Molecular Biology Therapies 52

Broad Institute

JANUARY 30, 2024

He majored in biological chemistry at the University of Chicago and during his junior year, he had a fortuitous meeting with his academic advisor about finding a student research position that would let him dive more deeply into the molecular details of biological systems. A combined MD/PhD program offered both opportunities.

Hospitals 137

Hospitals Medical Schools Virus Science 137

Elrig

APRIL 29, 2024

Joining Isomorphic Labs in October 2024, I’m thrilled to be part of their mission to revolutionize DD through AI/ML. Jasmine has a background in neuroscience and genetic manipulation, with early works focused on using a combined structural and molecular biology approach to assess disease-associated proteins implicated in Alzheimer’s disease.

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59

Drug Target Review

NOVEMBER 8, 2023

As we head into 2024, Vittoria is excited to advance the platform into the clinic, getting one step closer to bringing life changing therapies to patients in need. Team and leadership: how had Dr Carl June’s involvement influenced Vittoria’s direction and ambition?

Therapies 115

Therapies Engineering Molecular Biology Treatment 115

Drug Target Review

FEBRUARY 28, 2024

Dr Rochlin earned a PhD in Molecular Biology and Genetics from Weill Cornell Medical College, conducting research at Sloan Kettering Institute, and a BA in Biology from the University of Pennsylvania. Nat Cancer (2024 January 3). and MBA students with real-world consulting experiences. J Front Immunol 9:1409 (2018).

Therapies 104

Therapies Engineering Molecular Biology Immune Response 104

Drug Discovery World

NOVEMBER 9, 2023

Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting.

Engineering 130

Engineering Protein Production Therapies Science 130

Codon

DECEMBER 17, 2023

Molecular biology, as the field came to be called 3 , pushed biology from an object of study, driven forward by gentleman scientists and precocious country clergymen, into a tool with which to solve urgent problems. Book projects will launch in 2024.

Engineering 52

Engineering Molecular Biology Doctors DNA 52

Codon

APRIL 2, 2024

I was reading a lot of molecular biology papers about different systems, especially circadian clocks, and also a book called Biological Feedback , by Thomas and D’Ari, that sketched out really simple models for different kinds of feedback circuits. So many kinds of people have contributed to biology in different ways.

RNA 59

RNA Engineering Molecular Biology Synthetic Chemistry 59

Codon

JUNE 25, 2024

Ultimately, no matter the model organism or where it comes from, molecular biology will probably never approach the speed of computer programming. ” Kamal Nahas is a researcher-turned-journalist based in Oxford, UK, who covers stories in biology, health, and technology. ” Asimov Press (2024). pneumoniae cells.

DNA 97

DNA RNA Laboratories Engineering 97

Codon

JUNE 18, 2024

Even after a half-century of molecular biology research, scientists didn’t know until recently how gas vesicles physically trap gas while occluding water. ” Asimov Press (2024). angstroms, or roughly twice the length of a single carbon-carbon bond. Niko McCarty is a founder of Asimov Press.

Engineering 72

Engineering Laboratories International Clinical Trials 72

Agency IQ

JANUARY 19, 2024

BY RACHEL COE, MSC | JAN 17, 2024 12:16 AM CST Quick background on cell line development Despite technological advancements in synthetic biology, all biological products today make use of harvested cellular material (or “substrate”) in one way or another. The Specific Precautions section (6.2.7) also received some additions.

Science 40

Science Virus Production FDA 40

Codon

FEBRUARY 13, 2024

” A Global View Even as advances in computing and molecular biology usher in the era of a new, high-tech “phage therapy 2.0”, He is editor of The Biologist , a magazine published by the Royal Society of Biology, and author of The Good Virus: The Amazing Story and Forgotten Promise of the Phage.

Therapies 138

Therapies DNA Virus Clinical Trials 138

Drug Target Review

FEBRUARY 15, 2024

Advances in molecular biology have led to highly safe, efficient, and effective platforms, such as mRNA, that can be rapidly re-purposed for different pathogens, multiple pathogens, or new strains of evolving pathogens. 2023 [cited 2024 Jan 22]. 2023 [cited 2024 Jan 22]. 2019 [cited 2024 Jan 22]. 29, 2023] | U.S.

Drug Development 121

Drug Development Virus Vaccine Government 121